Bavarian Nordic AS operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bavarian Nordic AS with three other
miscellaneous service companies in Europe:
Pharma Mar SA
sales of 180.95 million Euro [US$194.36 million]
of which 62%
was Biotech Sector),
(1.56 billion Swedish Kronor [US$177.10 million]
of which 68%
was LabTech), and
based in Belgium
(151.60 million Euro [US$162.84 million]
Bavarian Nordic AS reported sales of 1.01 billion Danish Kroner (US$145.42 million)
December of 2016.
decrease of 1.4%
versus 2015, when the company's sales were 1.02 billion Danish Kroner.